
Human CXCL1 PicoKine ELISA Kit standard curve
Human CXCL1/Gro Alpha ELISA Kit PicoKine(r)
EK0722
Product group Assays
Overview
- SupplierBoster Bio
- Product NameHuman CXCL1 PicoKine ELISA Kit
- Delivery Days Customer9
- ApplicationsELISA
- Applications SupplierELI
- Assay Detection Range15.6 pg/ml - 1,000 pg/ml
- Assay Sensitivity<1 pg/ml
- Assay Time25-30
- CertificationResearch Use Only
- Scientific DescriptionHuman CXCL1/Gro Alpha ELISA Kit PicoKine® (96 Tests). Quantitate Human CXCL1 in cell culture supernatants, serum and plasma (heparin, EDTA, citrate). Sensitivity: 1pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
- Reactivity SupplierHuman CXCL1
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC41116158
References
- Xu Y, Xiang Z, E W, et al. Single-cell transcriptomes reveal a molecular link between diabetic kidney and retinal lesions. Commun Biol. 2023,6(1):912. doi: 10.1038/s42003-023-05300-4Read this paper
- Chen Y, Wang Y, Xu J, et al. Multiplex Assessment of Serum Chemokines CCL2, CCL5, CXCL1, CXCL10, and CXCL13 Following Traumatic Brain Injury. Inflammation. 2023,46(1):244-255. doi: 10.1007/s10753-022-01729-7Read this paper
- Man X, Yang X, Wei Z, et al. High expression level of CXCL1/GROα is linked to advanced stage and worse survival in uterine cervical cancer and facilitates tumor cell malignant processes. BMC Cancer. 2022,22(1):712. doi: 10.1186/s12885-022-09749-0Read this paper
- Tang H, Zhou X, Zhao X, et al. HSP90/IKK-rich small extracellular vesicles activate pro-angiogenic melanoma-associated fibroblasts via the NF-κB/CXCL1 axis. Cancer Sci. 2022,113(4):1168-1181. doi: 10.1111/cas.15271Read this paper
- Le Naour A, Prat M, Thibault B, et al. Tumor cells educate mesenchymal stromal cells to release chemoprotective and immunomodulatory factors. J Mol Cell Biol. 2020,12(3):202-215. doi: 10.1093/jmcb/mjz090Read this paper
- Shan Y, Shi K, Qian X, et al. Preclinical development of GR1501, a human monoclonal antibody that neutralizes interleukin-17A. Biochem Biophys Res Commun. 2019,517(2):303-309. doi: 10.1016/j.bbrc.2019.07.078Read this paper
- Su Y, Huang J, Zhao X, et al. Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation. Sci Immunol. 2019,4(36):pii: eaau9657. doi: 10.1126/sciimmunol.aau9657.Read this paper
- Chu CL, Zhao CH, Zhang ZW, et al. Identification and Validation of Gene Expression Patterns in Cystitis Glandularis Patients and Controls. SLAS Discov. 2017,22(6):743-750. doi: 10.1177/2472555216685519Read this paper
- Wee ZN, Yatim SM, Kohlbauer VK, et al. IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel. Nat Commun. 2015,6:8746. doi: 10.1038/ncomms9746Read this paper
- Kong J, Kong L, et al. After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma. J Transl Med. 2012,10:230. doi: 10.1186/1479-5876-10-230Read this paper



